The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development-Reference-Cited by-同舟云学术

The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development

Published:2015-04-27 Issue:5 Volume:17 Page:665-677
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Kang Xunlei,Lu Zhigang,Cui Changhao,Deng Mi,Fan Yuqi,Dong Baijun,Han Xin,Xie Fuchun,Tyner Jeffrey W.,Coligan John E.,Collins Robert H.,Xiao Xiangshu,You M. James,Zhang Cheng Cheng

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/ncb3158.pdf

Reference56 articles.

1. Maynadie, M. et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d’Or (Burgundy, France). Haematologica 96, 55–61 (2011).

2. Krause, D. S. & Van Etten, R. A. Right on target: eradicating leukemic stem cells. Trends Mol. Med. 13, 470–481 (2007).

3. Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645–648 (1994).

4. Lane, S. W., Scadden, D. T. & Gilliland, D. G. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood 114, 1150–1157 (2009).

5. Wei, J. et al. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell 13, 483–495 (2008).

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LILRB4 in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target;Chinese Medical Journal;2024-07-08

2. Inhibiting AGTR1 reduces AML burden and protects the heart from cardiotoxicity in mouse models;Science Translational Medicine;2024-06-19

3. LAIR1 prevents excess inflammatory tissue damage inS. aureusskin infection and Cutaneous T-cell Lymphoma;2024-06-16

4. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells;Nature Nanotechnology;2024-05-23

5. Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes;Blood Advances;2024-05-20